[ad_1] Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA). “Lupin today announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final […]
Lupin receives FDA approval for generic HIV tablets – CNBC TV18
[ad_1] Drug firm Lupin Ltd on Wednesday (December 18) announced that it has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for HIV tablets emtricitabine and tenofovir alafenamide tablets, 200 mg/25 mg. Company Value Change %Change “…we wish to confirm that the Company has received approval […]
Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim International – CNBC TV18
[ad_1] Drug firm Lupin Ltd on Friday (December 13) announced the acquisition of trademarks for three anti-diabetes brands — Gibtulio, Gibtulio Met, and Ajaduo — from Boehringer Ingelheim International GmbH. The acquisition is expected to bolster Lupin’s diabetes portfolio in India, a critical therapeutic segment for the company. Company Value Change %Change Under the terms […]